Benzinga | Jan 11, 2021 12:35PM EST

Boston Scientific Corp Sees About $100M-$150M Of Charges Will Impact Adjusted Results; Says Recall Expected To Result In Estimated Total Pre-GAAP Charges Of About $225M-$300M

-Reuters